397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer

Javier Carrasco, D Schröder, Isabelle Sinapi, Astrid De Cuyper, G. Beniuga, Sophie Delmarcelle, J-L. van Laethem, Nicolas D. Huyghe, Isabelle Bar, Alain Hendlisz, Karin Haustermans, Thierry Delaunoit, J.-C. Coche, Geneviève Van Ooteghem, A-S. Boulanger, Paméla Baldin, Marc Van den Eynde